Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease

Author： Guillin O.   Griffon N.   Bezard E.   Leriche L.   Diaz J.   Gross C.   Sokoloff P.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.480, Iss.1, 2003-11, pp. : 89-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Brain-Derived Neurotrophic Factor in the Aetiology of Depression: Implications for Pharmacological Treatment

By Castrén Eero   Rantamäki Tomi  

CNS Drugs, Vol. 24, Iss. 1, 2010-01 ,pp. : 1-7

Adis International

Access to resources Recommend Favorite

Brain-Derived Neurotrophic Factor and Antidepressant Activity

By  

Current Pharmaceutical Design, Vol. 11, Iss. 12, 2005-05 ,pp. : 1495-1510

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Brain-Derived Neurotrophic Factor (BDNF) Gene Variants on the Therapeutic Response and the Risk for Mood Disorders

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 6, Iss. 2, 2008-06 ,pp. : 126-133

Bentham Science Publishers

Access to resources Recommend Favorite

Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets

By  

Current Neuropharmacology, Vol. 14, Iss. 7, 2016-08 ,pp. : 721-731

Bentham Science Publishers

Access to resources Recommend Favorite

Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains

By Iritani S.   Niizato K.   Nawa H.   Ikeda K.   Emson P.C.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 5, 2003-08 ,pp. : 801-807

Elsevier

Access to resources Recommend Favorite